What is the minimum number of days I must wait after stopping flibanserin (Addyi) before drinking alcohol to avoid interaction‑related side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Minimum Waiting Period After Stopping Flibanserin Before Alcohol Consumption

You must wait at least 2 days (48 hours) after your last dose of flibanserin before drinking any alcohol to avoid dangerous hypotension and syncope.

Pharmacokinetic Rationale

  • Flibanserin has an elimination half-life of approximately 11 hours in healthy premenopausal women, meaning that after 2 days (approximately 4–5 half-lives), over 90% of the drug will be cleared from your system 1, 2.

  • The FDA-approved prescribing information for flibanserin carries a boxed warning contraindicating alcohol use during treatment due to significantly increased risk of severe hypotension and syncope 3, 4.

  • Clinical pharmacology studies demonstrate that the interaction between flibanserin and alcohol is pharmacodynamic (how the drugs affect your body together) rather than pharmacokinetic (how they are metabolized), meaning the risk persists as long as flibanserin remains in your system 3.

Evidence from Clinical Studies

  • In a phase 1 alcohol-interaction study, co-administration of flibanserin with alcohol (0.4–0.8 g/kg ethanol) resulted in significantly increased incidence of hypotension and syncope compared to either substance alone 3.

  • Sedation increased by 20–27% from baseline when flibanserin was combined with alcohol, with effects persisting for at least 4 hours post-dose 3.

  • Even when flibanserin was administered at bedtime (the recommended dosing schedule) 2.5 hours after moderate alcohol consumption with an evening meal, the combination was associated with increased adverse events, though the study was limited by small sample size 5.

Critical Safety Considerations

  • The risk of severe hypotension and syncope is dose-dependent for alcohol: higher alcohol doses (0.6 g/kg, approximately 3 standard drinks) produced more pronounced effects than lower doses when combined with flibanserin 2.

  • Timing studies showed that even when alcohol was consumed 2,4, or 6 hours before flibanserin dosing, the interaction risk remained, though these studies used daytime dosing rather than the recommended bedtime administration 1.

  • The most common adverse events with flibanserin alone include dizziness (11.4%), somnolence (11.2%), nausea (10.4%), and fatigue (9.2%)—all of which are significantly worsened by alcohol co-administration 4.

Recommended Waiting Period Algorithm

After your last flibanserin dose:

  • Day 1 (0–24 hours): Absolutely no alcohol—highest drug levels remain in your system.
  • Day 2 (24–48 hours): Continue to avoid all alcohol—approximately 75% of the drug has been eliminated.
  • Day 3 (48+ hours): You may cautiously resume moderate alcohol consumption—over 90% of flibanserin has been cleared 1, 2.

Common Pitfalls to Avoid

  • Do not assume that "just one drink" is safe during the first 48 hours after stopping flibanserin—even small amounts of alcohol (0.2 g/kg, approximately 1 standard drink) showed interaction effects in clinical studies 2.

  • Do not rely on feeling "normal" as an indicator that it is safe to drink—pharmacodynamic interactions can occur even when you feel no residual effects from flibanserin 3.

  • If you have liver or kidney impairment, you may need to wait longer than 2 days, as flibanserin clearance will be delayed—consult your prescriber for individualized guidance 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.